(R)-1-(4-aminobenzyl)-3-(2-(2-((4-benzyl-1H-1,2,3-triazol-1-yl)methyl)pyrrolidin-1-yl)-2-oxoethyl)urea | 1313214-43-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: (R)-1-(4-aminobenzyl)-3-(2-(2-((4-benzyl-1H-1,2,3-triazol-1-yl)methyl)pyrrolidin-1-yl)-2-oxoethyl)urea
• 英文别名: 1-[(4-aminophenyl)methyl]-3-[2-[(2R)-2-[(4-benzyltriazol-1-yl)methyl]pyrrolidin-1-yl]-2-oxoethyl]urea
• CAS: 1313214-43-5
• 化学式: C₂₄H₂₉N₇O₂
• 分子量: 447.54
• InChiKey: AOCXKDHKHFYFEG-JOCHJYFZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  33
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  118
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• NEW INHIBITORS OF CYCLOPHILINS AND USES THEREOF
  申请人：Guichou Jean-Francois

  公开号：US20130018044A1

  公开（公告）日：2013-01-17

  The present invention relates to a compound of formula (I): wherein: n is 0, 1 or 2; A is in particular CH or N; X is in particular CO, SO 2 , CS, and R 1 is in particular H, R 2 is a group of formula NR 3 R 4 or OR 5 , R 3 and R 4 being in particular H, and R 5 an alkyl group, R 6 is in particular H or an alkyl group, and R 7 is in particular an aryl group, for its use in the prevention and/or the treatment of viral pathologies or infections.

  本发明涉及式(I)的化合物：其中：n为0、1或2；A特别为CH或N；X特别为CO、SO2、CS，R1特别为H，R2为式NR3R4或OR5的基团，其中，R3和R4特别为H，R5为烷基，R6特别为H或烷基，R7特别为芳基，用于预防和/或治疗病毒病理或感染。
• INHIBITORS OF CYCLOPHILINS FOR USE IN THE PREVENTION AND/OR THE TREATMENT OF VIRAL PATHOLOGIES OR INFECTIONS
  申请人：Institut National de la Santé et de la Recherche Médicale (INSERM)

  公开号：EP2516387B1

  公开（公告）日：2018-02-21
• US8802666B2
  申请人：——

  公开号：US8802666B2

  公开（公告）日：2014-08-12
• [EN] NEW INHIBITORS OF CYCLOPHILINS AND USES THEREOF<br/>[FR] NOUVEAUX INHIBITEURS DE CYCLOPHILINES ET LEURS UTILISATIONS
  申请人：INST NAT SANTE RECH MED

  公开号：WO2011076784A2

  公开（公告）日：2011-06-30

  The present invention relates to a compound of formula (I): Formula (I), wherein: - n is 0, 1 or 2; - A is in particular CH or N; - X is in particular CO, SO2, CS, and R1 is in particular H, - R2 is a group of formula NR3R4 or OR5, R3 and R4 being in particular H, and R5 an alkyl group, - R6 is in particular H or an alkyl group, and - R7 is in particular an aryl group, for its use in the prevention and/or the treatment of viral pathologies or infections.